SCHEMBL5677100

SCHEMBL5677100

CCCc1ccc(OC(=O)O)c(O)c1C[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.37
▸ CYP1A2 P05177 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ LTB4R Q15722 1/20 0.32
▸ LTB4R2 Q9NPC1 1/20 0.32
▸ ELANE P08246 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ PPARG P37231 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ GRM2 Q14416 1/20 0.32
▸ PTPN1 P18031 2/20 0.31
▸ PTPN11 Q06124 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588622 0.87 PRKCI (0.41) PRKCICYP1A2MAPTMEN1TSHR
SCHEMBL5680760 0.85 PRKCI (0.41) PRKCICYP1A2MAPTMEN1TSHR
SCHEMBL5676413 0.83 PRKCI (0.39) PRKCICYP1A2MAPTMEN1TSHR
SCHEMBL5676396 0.82 ALOX5 (0.41) PRKCITSHRLTB4RLTB4R2PPARG
SCHEMBL5680670 0.81 CYP1A2 (0.40) PRKCICYP1A2MAPTMEN1TSHR
SCHEMBL5590253 0.80 CYP1A2 (0.40) CYP1A2MAPTMEN1TSHRKMT2A
SCHEMBL5919954 0.79 PPARA (0.38) TSHRELANEPPARGPPARDPPARA
SCHEMBL5677027 0.79 ALOX5 (0.42) TSHRPPARGPPARA
SCHEMBL5681229 0.79 FFAR4 (0.31) CYP1A2MAPTMEN1TSHRKMT2A
SCHEMBL5586648 0.78 TYR (0.40) CYP1A2MAPTMEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 — — US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 — — EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR PRKCI 4096/4885CYP1A2 1942/4885MAPT 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback